Increasing scrutiny and an evolving understanding of the impact of capsid impurities in recombinant adeno-associated virus (rAAV)-based therapies has catalyzed efforts to eliminate them from ...
Simulations Plus (SLP) announced that it has been awarded a newly funded grant from the U.S. Food and Drug Administration FDA to use physiologically based pharmacokinetic PBPK approaches in GastroPlus ...
For AI to truly be groundbreaking for neuroscience, Pavlick asserted, it is essential to understand how the machine itself ...
This work reviews CM-cfDNA methods applied to clinical oncology, emphasizing both machine learning (ML) techniques and mechanistic approaches. The latter integrate biological principles, enabling a ...
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that ...
A new spinoff company is about to launch a computer model that aims to accelerate process development by speeding up the optimization of cell culture media. AuctuCel, which plans to open for business ...
But last year we got the best sense yet of how LLMs function, as researchers at top AI companies began developing new ways to ...
In the rapidly evolving world of Large Language Models (LLMs), a quiet but critical tug-of-war is taking place over how we ...
Progress in mechanistic interpretability could lead to major advances in making large AI models safe and bias-free. The Anthropic researchers, in other words, wanted to learn about the higher-order ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results